A molecular network of the aging brain implicates INPPL1 and PLXNB1 in Alzheimer’s disease
Citations Over Time
Abstract
Abstract The fact that only symptomatic therapies of small effect are available for Alzheimer’s disease (AD) today highlights the need for new therapeutic targets with which to prevent a major contributor to aging-related cognitive decline. Here, we report the construction and validation of a molecular network of the aging human frontal cortex. Using RNA sequence data from 478 individuals, we first identify the role of modules of coexpressed genes, and then confirm them in independent AD datasets. Then, we prioritize influential genes in AD-related modules and test our predictions in human model systems. We functionally validate two putative regulator genes in human astrocytes: INPPL1 and PLXNB1 , whose activity in AD may be related to semaphorin signalling and type II diabetes, which have both been implicated in AD. This arc of network identification followed by statistical and experimental validation provides specific new targets for therapeutic development and illustrates a network approach to a complex disease. One sentence summary Molecular network analysis of RNA sequencing data from the aging human cortex identifies new Alzheimer’s and cognitive decline genes.
Related Papers
- → Spectroscopic analysis for the arc quenching effect of ablation gas on arc immobility phenomena(2002)4 cited
- → An Experiment on the Relationship between Arc Duration and Resistanec in Ag Contacts at Low Opening Speed(1993)
- → The influence of electrodes resistance on arc motion between a pair of parallel electrodes(2011)
- Arc expression and protein-protein interactions in a mouse model of Alzheimer’s disease. Exercise- and novelty-induced changes in Arc, BDNF, and PS1 expression and Arc PS1 interaction in APP/PS1 and WT mice(2017)
- → Weak chainability of arc folders(2020)